Toxicity of antineoplastic chemotherapy in children

Theodore Zwerdling, Steven K. Bergstrom, Stephen D. Smith

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The basic principles of pediatric drug therapy and toxicity were initially founded on the premise that the infant was simply a small adult. Over the last 20 years, it has been found that this concept is therapeutically inaccurate. Of necessity this has led to intensive investigation into the identification and elucidation of developmental parameters that influence clinical pharmacology. Within the field of pediatric pharmacology, it is generally accepted that there are a number of unique developmental stages which must be considered with respect to drug effect and toxicity. The developmental stages are related to the mode of exposure as follows: In utero the fetus may be inadvertently exposed to drugs secondary to maternal chemical ingestion. The neonate may encounter drugs as a result of maternal administration via the breast milk. At this stage, direct drug exposure can also occur. The older infant and child are no longer subject to lactational exposure, but merely to the direct route.

Original languageEnglish (US)
Title of host publicationDrug Toxicity and Metabolism in Pediatrics
PublisherCRC Press
Pages185-219
Number of pages35
ISBN (Electronic)9781351079976
ISBN (Print)9781315892429
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Antineoplastic Agents
Drug-Related Side Effects and Adverse Reactions
Drug Therapy
Mothers
Pharmaceutical Preparations
Pediatrics
Clinical Pharmacology
Human Milk
Fetus
Eating
Newborn Infant
Pharmacology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Zwerdling, T., Bergstrom, S. K., & Smith, S. D. (2018). Toxicity of antineoplastic chemotherapy in children. In Drug Toxicity and Metabolism in Pediatrics (pp. 185-219). CRC Press. https://doi.org/10.1201/9781351071529

Toxicity of antineoplastic chemotherapy in children. / Zwerdling, Theodore; Bergstrom, Steven K.; Smith, Stephen D.

Drug Toxicity and Metabolism in Pediatrics. CRC Press, 2018. p. 185-219.

Research output: Chapter in Book/Report/Conference proceedingChapter

Zwerdling, T, Bergstrom, SK & Smith, SD 2018, Toxicity of antineoplastic chemotherapy in children. in Drug Toxicity and Metabolism in Pediatrics. CRC Press, pp. 185-219. https://doi.org/10.1201/9781351071529
Zwerdling T, Bergstrom SK, Smith SD. Toxicity of antineoplastic chemotherapy in children. In Drug Toxicity and Metabolism in Pediatrics. CRC Press. 2018. p. 185-219 https://doi.org/10.1201/9781351071529
Zwerdling, Theodore ; Bergstrom, Steven K. ; Smith, Stephen D. / Toxicity of antineoplastic chemotherapy in children. Drug Toxicity and Metabolism in Pediatrics. CRC Press, 2018. pp. 185-219
@inbook{34a7cc0aafd7404c89509739e5d6c894,
title = "Toxicity of antineoplastic chemotherapy in children",
abstract = "The basic principles of pediatric drug therapy and toxicity were initially founded on the premise that the infant was simply a small adult. Over the last 20 years, it has been found that this concept is therapeutically inaccurate. Of necessity this has led to intensive investigation into the identification and elucidation of developmental parameters that influence clinical pharmacology. Within the field of pediatric pharmacology, it is generally accepted that there are a number of unique developmental stages which must be considered with respect to drug effect and toxicity. The developmental stages are related to the mode of exposure as follows: In utero the fetus may be inadvertently exposed to drugs secondary to maternal chemical ingestion. The neonate may encounter drugs as a result of maternal administration via the breast milk. At this stage, direct drug exposure can also occur. The older infant and child are no longer subject to lactational exposure, but merely to the direct route.",
author = "Theodore Zwerdling and Bergstrom, {Steven K.} and Smith, {Stephen D.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1201/9781351071529",
language = "English (US)",
isbn = "9781315892429",
pages = "185--219",
booktitle = "Drug Toxicity and Metabolism in Pediatrics",
publisher = "CRC Press",

}

TY - CHAP

T1 - Toxicity of antineoplastic chemotherapy in children

AU - Zwerdling, Theodore

AU - Bergstrom, Steven K.

AU - Smith, Stephen D.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The basic principles of pediatric drug therapy and toxicity were initially founded on the premise that the infant was simply a small adult. Over the last 20 years, it has been found that this concept is therapeutically inaccurate. Of necessity this has led to intensive investigation into the identification and elucidation of developmental parameters that influence clinical pharmacology. Within the field of pediatric pharmacology, it is generally accepted that there are a number of unique developmental stages which must be considered with respect to drug effect and toxicity. The developmental stages are related to the mode of exposure as follows: In utero the fetus may be inadvertently exposed to drugs secondary to maternal chemical ingestion. The neonate may encounter drugs as a result of maternal administration via the breast milk. At this stage, direct drug exposure can also occur. The older infant and child are no longer subject to lactational exposure, but merely to the direct route.

AB - The basic principles of pediatric drug therapy and toxicity were initially founded on the premise that the infant was simply a small adult. Over the last 20 years, it has been found that this concept is therapeutically inaccurate. Of necessity this has led to intensive investigation into the identification and elucidation of developmental parameters that influence clinical pharmacology. Within the field of pediatric pharmacology, it is generally accepted that there are a number of unique developmental stages which must be considered with respect to drug effect and toxicity. The developmental stages are related to the mode of exposure as follows: In utero the fetus may be inadvertently exposed to drugs secondary to maternal chemical ingestion. The neonate may encounter drugs as a result of maternal administration via the breast milk. At this stage, direct drug exposure can also occur. The older infant and child are no longer subject to lactational exposure, but merely to the direct route.

UR - http://www.scopus.com/inward/record.url?scp=85053171782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053171782&partnerID=8YFLogxK

U2 - 10.1201/9781351071529

DO - 10.1201/9781351071529

M3 - Chapter

SN - 9781315892429

SP - 185

EP - 219

BT - Drug Toxicity and Metabolism in Pediatrics

PB - CRC Press

ER -